MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • MDS Virtual Congress 2020

    The dysfunctional autonomic function and “dysfunctional” fatigue in drug naïve Parkinson’s disease

    J.H Ahn, M. Kim, J.K Mun, J.S Kim, J. Song, J. Youn, J.S Kim, J.W Cho (Seoul, Republic of Korea)

    Objective: In the present study, the relationship between fatigue and autonomic dysfunction in drug-naïve PD patients was investigated. Background: Fatigue is a common and disabling…
  • MDS Virtual Congress 2020

    Quantitative Autonomic Testing in Parkinson’s Disease

    S.M Cheon, G.B Lee, J.W Kim (Busan, Republic of Korea)

    Objective: This study was done to find the clinical correlates with quantitative autonomic testing in Parkinson's disease. Background: Autonomic dysfunction is common and causes variety…
  • MDS Virtual Congress 2020

    Orthostatic hypotension in Parkinson’s disease

    L. Dommershuijsen, A. Heshmatollah, P. Koudstaal, M. Ikram, M. Ikram (Rotterdam, Netherlands)

    Objective: We aimed to identify whether orthostatic hypotension (OH) is a prodromal marker of Parkinson’s disease (PD) or a symptom of later disease. Background: Many…
  • MDS Virtual Congress 2020

    Autonomic symptoms as biomarkers in REM Sleep Behavior Disorder and Parkinson’s disease

    W. Hermann, L. Ecke, D. Wittig, D. Hausbrand, M. Brandt, H. Reichmann, A. Storch, T. Ziemssen (Dresden, Germany)

    Objective: This study was designed to evaluate autonomic functions in iRBD compared to PD and controls including longitudinal follow-up assessments to evaluate their potential to…
  • 2019 International Congress

    Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients

    J. Kenna, S. Mcgregor, M. Horne, A. Tay, S. Ghosh, F. Mastaglia, A. Jefferson, A. Gorecki, M. Bakeberg, S. Walters, R. Anderton (Perth, Australia)

    Objective: Parkinson’s disease (PD) is associated with an assortment of difficult to recognize non-motor symptoms, including gastrointestinal (GI) dysfunction. Recently, there have been studies reporting…
  • 2019 International Congress

    Dysautonomia as a predictor of cognitive outcome after deep brain stimulation in Parkinson’s disease

    V. Cabreira, P. Castro, J. Freitas, M. Rosas, E. Azevedo (Porto, Portugal)

    Objective: To evaluate cognitive effects of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD) and to investigate whether subclinical autonomic dysfunction may…
  • 2019 International Congress

    Ambulatory monitoring of electrodermal activity (EDA) and Heart Rate Variability (HRV) for prediction of motor fluctuations in Parkinson’s Disease (PD)

    D. Nene, P. Surathi, M. Mirian, W. Doo, M. Mckeown (Vancouver, BC, Canada)

    Objective: To determine whether changes in EDA and HRV are associated with motor fluctuations in patients with PD Background: EDA and HRV are affected in…
  • 2019 International Congress

    Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease

    O. Alenikova, S. Likhchev, A. Buniak, M. Liashkovich (Minsk, Belarus)

    Objective: To assess the daily variability of visual and autonomic nervous system (ANS) functions in relation to sleep disorders to determine circadian PD phenotypes Background:…
  • 2019 International Congress

    Differences in resting state fMRI distinguish multiple system atrophy and Parkinson disease

    A. Peterson, E. Dayan, N. Browner, D. Drazheva, M. Sklerov (Chapel Hill, NC, USA)

    Objective: To investigate whether functional connectivity of the hypothalamus can distinguish multiple system atrophy from Parkinson disease. Background: Multiple system atrophy parkinsonian subtype (MSA-P) and…
  • 2019 International Congress

    Deceleration capacity of heart rate: is cardiac vagal modulation impaired in idiopathic Parkinson’s disease?

    C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schüle, S. Goldman, M. Estevez, P. Stein, A. Lang, H. Jelinek, A. Machado (La Habana, Cuba)

    Objective: Assessment of cardiac vagal modulation through the analysis of heart rate deceleration capacity (DC) in idiopathic Parkinson’s disease (PD). Background: Cardiac autonomic dysfunction manifests…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley